Dr.Β XiaojunΒ Huang
MD, PhD
Professor, Chief Physician & Academician β Haematology & Stem Cell Transplantation
corporate_farePeking University People's Hospital, Beijing
Xiaojun Huang
MD, PhD
Prof. Xiaojun Huang is one of China's most distinguished haematologists, serving as Professor, Chief Physician, and Director of the Department of Hematology at Peking University People's Hospital in Beijing. He is also Director of the Peking University Institute of Hematology and Director of the National Clinical Research Center for Hematologic Diseases, and was elected an Academician of the Chinese Academy of Engineering in 2023.
With more than 37 years of clinical and research experience at Peking University People's Hospital, Prof. Huang has dedicated his career to the treatment of leukemia and malignant blood diseases through haematopoietic stem cell transplantation. He is internationally recognised as the creator of the 'Beijing Protocol,' a haploidentical bone marrow transplantation approach that expanded related-donor availability from under 25% to nearly 100% for patients who lack a fully matched sibling donor. His team's ongoing research continues to refine donor selection, transplant safety, and long-term outcomes β including 2026 multicenter evidence in severe aplastic anemia demonstrating that donor age may outweigh full HLA matching in certain transplant settings. In 2024, Prof. Huang received the CIBMTR Distinguished Service Award for his contributions to international haematology and blood and marrow transplantation.
CancerFax can coordinate medical-report review and consultation support for international patients seeking expert haematology or stem cell transplantation evaluation from Prof. Huang's team at Peking University People's Hospital.
Why Consider Prof. Xiaojun Huang?
Prof. Huang is among the world's leading authorities on haploidentical bone marrow transplantation and leukemia, combining decades of clinical leadership with landmark research that has transformed transplant medicine globally.
Areas of Specialisation
Leukemia, malignant blood diseases, and haematopoietic stem cell transplantation
Prof. Huang's clinical and research specialisation centres on haematopoietic stem cell transplantation β particularly haploidentical transplantation β as well as the diagnosis and treatment of leukemia and other malignant hematologic diseases.
Haematopoietic Stem Cell Transplantation
Advanced transplant strategies for leukemia and blood diseases, including haploidentical approaches for patients without fully matched donors.
- arrow_rightBeijing Protocol β unmanipulated haploidentical transplant without in-vitro T-cell depletion
- arrow_rightG-CSF and ATG-based conditioning strategies for haploidentical transplantation
- arrow_rightRelated-donor selection when a fully HLA-matched sibling is unavailable
- arrow_rightExpanded donor access using parents, children, and other relatives
- arrow_rightMatched sibling and matched unrelated donor transplantation
- arrow_rightTransplant conditioning and engraftment management
- arrow_rightPrevention and management of graft-versus-host disease (GVHD)
- arrow_rightPost-transplant immune reconstitution and relapse prevention
Leukemia & Malignant Blood Diseases
Comprehensive clinical management of acute and chronic leukemia, aplastic anaemia, and related malignant haematologic conditions.
- arrow_rightAcute myeloid leukemia (AML) β induction, consolidation, and transplant planning
- arrow_rightAcute lymphoblastic leukemia (ALL) β risk-stratified treatment approaches
- arrow_rightPost-remission transplant strategies for intermediate- and high-risk AML
- arrow_rightAllogeneic stem cell transplantation for severe aplastic anaemia
- arrow_rightDonor-age-based selection strategies informed by multicenter research
- arrow_rightLong-term outcomes optimisation in transplant-eligible patients
Procedures Performed
Transplant, haematology, and related clinical services
Prof. Huang's clinical practice covers the full spectrum of haematopoietic stem cell transplantation and haematology management, from initial diagnosis and treatment planning through to post-transplant monitoring and complication management.
Haploidentical Stem Cell Transplantation
TransplantUnmanipulated haploidentical bone marrow or peripheral blood stem cell transplantation using the Beijing Protocol for patients without a fully matched donor.
Allogeneic Stem Cell Transplantation
TransplantMatched sibling, matched unrelated, and other allogeneic transplant strategies for leukemia and blood diseases.
Leukemia & Haematology Management
Medical OncologyComprehensive induction, consolidation, and post-remission treatment planning for leukemia and malignant blood diseases.
Post-Transplant Monitoring & Complication Management
MonitoringLong-term monitoring and active management of transplant-related complications, relapse, and immune recovery.
Second Opinion Consultation
Second OpinionExpert independent review for patients with leukemia, aplastic anaemia, or blood diseases requiring transplant or complex haematology decisions.
Research & Publications
Landmark contributions in haploidentical transplantation, leukemia, and haematology
Prof. Huang has made internationally recognised research contributions in haploidentical bone marrow transplantation, leukemia treatment, donor selection, and transplant outcomes. His Google Scholar profile, associated with Peking University People's Hospital, shows more than 8,600 indexed citations.
Prof. Huang's full publication list is available via Google Scholar (Huang XJ, Peking University People's Hospital). A more detailed list may be requested through CancerFax.
Education & Training
Prof. Huang completed his medical and doctoral training in China and undertook international research training at Albert Einstein College of Medicine, New York.
Clinical Experience
Prof. Huang has served at Peking University People's Hospital for more than 37 years, building one of China's foremost haematology and bone marrow transplantation programmes, as reported by the hospital in 2024.
Languages & International
Prof. Huang conducts clinical consultations and academic work in Chinese (Mandarin). English is used for academic publications and international collaboration.
CancerFax can coordinate professional medical interpreter support for international patients consulting with Prof. Huang's team at Peking University People's Hospital.
CancerFax can coordinate professional medical interpreter support for international patients, including English, Arabic, Russian, and other languages.
How CancerFax Helps You Access Dr. Xiaojun Huang
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Xiaojun Huang's team β with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history β prepared as a structured clinical summary for Dr. Xiaojun Huang's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Xiaojun Huang before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Xiaojun Huang's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Xiaojun Huang's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Xiaojun Huang's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Xiaojun Huang
Prof. Huang is internationally recognised for developing the Beijing Protocol β a haploidentical bone marrow transplantation approach that expanded related-donor availability from under 25% to nearly 100% for patients who lack a fully HLA-matched sibling donor. He was elected an Academician of the Chinese Academy of Engineering in 2023 and received the CIBMTR Distinguished Service Award in 2024.
Prof. Huang specialises in leukemia β including acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) β other malignant haematologic diseases, and severe aplastic anaemia. His official hospital profile confirms a long-term focus on leukemia and conditions requiring haematopoietic stem cell transplantation.
The Beijing Protocol is a haploidentical bone marrow transplantation strategy developed by Prof. Huang and his team. It uses an unmanipulated approach β without in-vitro T-cell depletion β combined with G-CSF and ATG-based conditioning. The protocol transformed haploidentical transplantation from a high-risk alternative into a widely used treatment model, and is now applied at transplant centres globally.
Yes. The Beijing Protocol was specifically designed to help patients who do not have a fully HLA-matched sibling donor. By using haploidentical (half-matched) relatives β such as parents, children, or siblings β as donors, the approach has made transplantation accessible to nearly all patients who require it, subject to clinical eligibility and case review.
Submit your medical reports, bone marrow biopsy results, and relevant test results through CancerFax using the 'Send Your Reports' button. The CancerFax team will review the case, prepare a structured summary, and coordinate the next steps with Peking University People's Hospital, subject to availability and case acceptance.
Peking University People's Hospital has an Office of International Affairs and External Cooperation. CancerFax can assist in coordinating report review and consultation support for international patients. Specific appointment pathways, teleconsultation availability, and interpreter arrangements should be confirmed through CancerFax prior to travel.
Connect with Xiaojun Huang Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.